Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-29

Clinical Trial Update: MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii

View source ↗

Summary

A clinical trial investigating molecular characterization and treatment of thyroid carcinoma arising in struma ovarii (ovarian cancer) was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut Bergonié | Conditions: Ovarian Cancer | Status: WITHDRAWN